| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Kauser Yousuf, Hadiza Ibrahim, Mahfoud Elbashari, Mohamed E Abouelnaga, Amani Alzaab. A Case of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Peripheral Neuropathy With Positive Anti-Myelin Oligodendrocyte (MOG) Antibodies. Cureus. vol 15. issue 10. 2023-12-04. PMID:38046503. |
a case of eosinophilic granulomatosis with polyangiitis (egpa) peripheral neuropathy with positive anti-myelin oligodendrocyte (mog) antibodies. |
2023-12-04 |
2023-12-10 |
Not clear |
| Kauser Yousuf, Hadiza Ibrahim, Mahfoud Elbashari, Mohamed E Abouelnaga, Amani Alzaab. A Case of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Peripheral Neuropathy With Positive Anti-Myelin Oligodendrocyte (MOG) Antibodies. Cureus. vol 15. issue 10. 2023-12-04. PMID:38046503. |
recent research has shown an association between myelin oligodendrocyte glycoprotein (mog) antibodies and various neurologic conditions. |
2023-12-04 |
2023-12-10 |
Not clear |
| Jennifer M Loftis, Sankrith Ramani, Evan J Firsick, Rebekah Hudson, Anh Le-Cook, Kevin S Murnane, Arthur Vandenbark, Renee L Shirle. Immunotherapeutic treatment of inflammation in mice exposed to methamphetamine. Frontiers in psychiatry. vol 14. 2023-12-01. PMID:38025429. |
we have shown that partial (p)mhc class ii constructs (i.e., recombinant t-cell receptor ligand - rtl1000), comprised of the extracellular α1 and β1 domains of mhc class ii molecules linked covalently to myelin oligodendrocyte glycoprotein (mog)-35-55 peptide, can address the neuroimmune effects of methamphetamine addiction through its ability to bind to and down-regulate cd74 expression, block macrophage migration inhibitory factor (mif) signaling, and reduce levels of pro-inflammatory chemokine ligand 2 (ccl2). |
2023-12-01 |
2023-12-07 |
mouse |
| Jennifer M Loftis, Sankrith Ramani, Evan J Firsick, Rebekah Hudson, Anh Le-Cook, Kevin S Murnane, Arthur Vandenbark, Renee L Shirle. Immunotherapeutic treatment of inflammation in mice exposed to methamphetamine. Frontiers in psychiatry. vol 14. 2023-12-01. PMID:38025429. |
we have shown that partial (p)mhc class ii constructs (i.e., recombinant t-cell receptor ligand - rtl1000), comprised of the extracellular α1 and β1 domains of mhc class ii molecules linked covalently to myelin oligodendrocyte glycoprotein (mog)-35-55 peptide, can address the neuroimmune effects of methamphetamine addiction through its ability to bind to and down-regulate cd74 expression, block macrophage migration inhibitory factor (mif) signaling, and reduce levels of pro-inflammatory chemokine ligand 2 (ccl2). |
2023-11-29 |
2023-12-07 |
mouse |
| Donglei Liao, Linxiu Zhong, Lifen Yang, Fang He, Xiaolu Deng, Fei Yin, Jing Pen. Clinical and radiological features, treatment responses and prognosis in pediatric patients with co-existing anti-N-methyl-D-aspartate receptor and myelin oligodendrocyte glycoprotein antibody-associated encephalitis: A single center study. Multiple sclerosis and related disorders. vol 81. 2023-11-20. PMID:37984120. |
to characterize the clinical and radiological features, treatment responses and outcomes of children with co-existing anti-n-methyl-d-aspartate receptor(nmdar) and myelin oligodendrocyte glycoprotein(mog) antibody-associated encephalitis. |
2023-11-20 |
2023-11-29 |
Not clear |
| Mirasol Forcadela, Chiara Rocchi, Daniel San Martin, Emily L Gibbons, Daniel Wells, Mark R Woodhall, Patrick J Waters, Saif Huda, Shahd Hami. Timing of MOG-IgG Testing Is Key to 2023 MOGAD Diagnostic Criteria. Neurology(R) neuroimmunology & neuroinflammation. vol 11. issue 1. 2023-11-17. PMID:37977848. |
myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad) is a recently identified autoimmune demyelinating disorder of the cns affecting both adults and children. |
2023-11-17 |
2023-11-20 |
Not clear |
| Ranjithkumar Rajendran, Vinothkumar Rajendran, Gregor Böttiger, Christine Stadelmann, Kian Shirvanchi, Laureen von Au, Sudhanshu Bhushan, Natascha Wallendszus, Darja Schunin, Victor Westbrock, Gerhard Liebisch, Süleyman Ergün, Srikanth Karnati, Martin Berghof. The small molecule fibroblast growth factor receptor inhibitor infigratinib exerts anti-inflammatory effects and remyelination in a model of multiple sclerosis. British journal of pharmacology. vol 180. issue 23. 2023-11-16. PMID:37400950. |
here, we investigate the effects of infigratinib on prevention and suppression of first clinical episodes of myelin oligodendrocyte glycoprotein (mog) |
2023-11-16 |
2023-11-20 |
Not clear |
| Giacomo Greco, Elena Colombo, Matteo Gastaldi, Lara Ahmad, Eleonora Tavazzi, Roberto Bergamaschi, Eleonora Rigon. Beyond Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibodies: Alternative Causes of Optic Neuritis. International journal of molecular sciences. vol 24. issue 21. 2023-11-14. PMID:37958968. |
atypical forms are characterized by unusual features, such as prominent optic disc edema, poor treatment response, and bilateral involvement, and they are often associated with autoantibodies against aquaporin-4 (aqp4) or myelin oligodendrocyte glycoprotein (mog). |
2023-11-14 |
2023-11-20 |
Not clear |
| Qingxi Fu, Guangying Wang, Fengyuan Che, Dong Li, Shougang Wan. FLAIR-hyperintense lesions in anti-MOG-associated encephalitis with seizures overlaying anti-N-methyl-D-aspartate receptor encephalitis: A case report. Medicine. vol 102. issue 45. 2023-11-14. PMID:37960781. |
flair-hyperintense lesions in anti-myelin oligodendrocyte glycoprotein (mog)-associated encephalitis with seizures (flames) is a rare clinical phenotype of anti-mog; immunoglobulin g-associated disease is often misdiagnosed as viral encephalitis in the early stages. |
2023-11-14 |
2023-11-20 |
Not clear |
| Anna S Thomann, Courtney A McQuade, Katarina Pinjušić, Anna Kolz, Rosa Schmitz, Daisuke Kitamura, Hartmut Wekerle, Anneli Peter. A B cell-driven EAE mouse model reveals the impact of B cell-derived cytokines on CNS autoimmunity. Proceedings of the National Academy of Sciences of the United States of America. vol 120. issue 47. 2023-11-13. PMID:37956299. |
here, we compared properties of myelin oligodendrocyte glycoprotein (mog)-specific and polyclonal b cells and developed an adjuvant-free cotransfer eae mouse model, where highly activated, mog-specific induced germinal center b cells provide the critical stimulus for disease development. |
2023-11-13 |
2023-11-20 |
mouse |
| Julian Bucur, Klemens Paul Kaiser, Marvin Lucas Biller, Tyll Jandewerth, Ninel Kenikstul, Thomas Kohne. [Bilateral Myelin oligodendrocyte glycoprotein (MOG)antibody-associated optic nerve neuritis]. Die Ophthalmologie. 2023-11-07. PMID:37934235. |
[bilateral myelin oligodendrocyte glycoprotein (mog)antibody-associated optic nerve neuritis]. |
2023-11-07 |
2023-11-08 |
Not clear |
| Linda Nguyen, Darryl K Miles, Lana Harder, Sumit Singh, Brett A Whittemore, Benjamin M Greenberg, Cynthia X Wan. Increased Intracranial Pressure in Pediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. Neurology(R) neuroimmunology & neuroinflammation. vol 11. issue 1. 2023-11-02. PMID:37918972. |
elevated intracranial pressure (icp) in myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad) has been largely unexplored. |
2023-11-02 |
2023-11-08 |
Not clear |
| Zhen Qian, Ke Zheng, Yanxuan Xu, Si Chen, Shaowan Chen, Jiajian Liang, Yingjie Cao, Tsz Kin Ng, Kunliang Qi. Longitudinal in vivo evaluation of retinal ganglion cell complex layer and dendrites in mice with experimental autoimmune encephalomyelitis. Experimental eye research. 2023-11-01. PMID:37913917. |
experimental autoimmune encephalomyelitis (eae), induced by the immunization of myelin oligodendrocyte glycoprotein (mog), is related to human mog antibody-associated disease (mogad). |
2023-11-01 |
2023-11-08 |
mouse |
| Mohamad Azlan Zaini, Ayesha Mohd Zain, Norshamsiah Md Din, Chenshen La. Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in a post-COVID-19 infection patient. Immunity, inflammation and disease. vol 11. issue 10. 2023-10-31. PMID:37904693. |
we report a case of myelin oligodendrocyte glycoprotein (mog) related optic neuritis in a sars-cov-2 (covid-19) patient. |
2023-10-31 |
2023-11-08 |
Not clear |
| Simone Sacco, Akash Virupakshaiah, Nico Papinutto, Vinicius A Schoeps, Amit Akula, Haojun Zhao, Jennifer Arona, William A Stern, Janet Chong, Janace Hart, Scott S Zamvil, Pascal Sati, Roland G Henry, Emmanuelle Wauban. Susceptibility-based imaging aids accurate distinction of pediatric-onset MS from myelin oligodendrocyte glycoprotein antibody-associated disease. Multiple sclerosis (Houndmills, Basingstoke, England). 2023-10-28. PMID:37897254. |
myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad) and pediatric-onset multiple sclerosis (poms) share clinical and magnetic resonance imaging (mri) features but differ in prognosis and management. |
2023-10-28 |
2023-11-08 |
Not clear |
| Jonathan D Krett, Marvin J Fritzler, Katayoun Alikhani, Jodie M Burto. A Quality Assessment of Aquaporin-4 & Myelin Oligodendrocyte Glycoprotein Antibody Testing. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. vol 50. issue 6. 2023-10-23. PMID:36398407. |
accurate anti-aquaporin-4 (aqp4) and anti-myelin oligodendrocyte glycoprotein (mog) autoantibody assays are needed to effectively diagnose neuromyelitis optica spectrum disorder and mog antibody-associated disease. |
2023-10-23 |
2023-11-08 |
Not clear |
| Yohane Gadama, Marié Du Preez, Jonathan Carr, Sarel Theron, Christine Albertyn, Kenneth Ssebambulidde, Deanna Saylor, Naeem Brey, Franclo Hennin. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and Human Immunodeficiency virus infection: dilemmas in diagnosis and management: a case series. Journal of medical case reports. vol 17. issue 1. 2023-10-16. PMID:37845760. |
we report three patients with hiv infection and myelin oligodendrocyte glycoprotein (mog) antibodies in the setting of other central nervous system infections. |
2023-10-16 |
2023-11-08 |
human |
| Ankit Bhardwaj, Hara Prasad Mishra, Ayush Goel, Ashi Gupt. COVID-19 - a potential trigger for MOGAD-associated optic neuritis: a case report and literature review. Therapeutic advances in ophthalmology. vol 15. 2023-10-09. PMID:37808590. |
we are reporting a case of a middle-aged adult diagnosed with myelin oligodendrocyte glycoprotein (mog) antibody-positive optic neuritis of the right eye post-covid-19 disease. |
2023-10-09 |
2023-10-15 |
Not clear |
| Michael Adamaszek, Soenke Langner, Jan Mehrholz, Alexander Heiinric. Opsoclonus-Myoclonus-Ataxia Syndrome Due to Covid-19. Cerebellum (London, England). 2023-10-09. PMID:37814146. |
of particular note, cerebrospinal fluid (csf) analysis revealed the production of myelin oligodendrocyte glycoprotein (mog) antibodies, suggesting an underlying neuroimmunological mechanism associated with infection with the novel sars-cov-2 virus. |
2023-10-09 |
2023-10-15 |
Not clear |
| Wei Zeng, Lu Yu, Jiarui Wu, Fang Wang, Xudong Liu, Shuqun Ren, Daxue Zhang, Baorong Lian, Minghua Hu, Liming Ca. Clinical characteristics and long-term follow-up outcomes of myelin oligodendrocyte glycoprotein antibody-associated disease in Han Chinese participants. Medicine. vol 102. issue 40. 2023-10-06. PMID:37800805. |
myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad) is an immune-mediated inflammatory demyelinating disease of the central nervous system. |
2023-10-06 |
2023-10-07 |
human |